Skip to main content
Article thumbnail
Location of Repository

PPARγ Variant Influences Angiographic Outcome and 10-Year Cardiovascular Risk in Male Symptomatic Coronary Artery Disease Patients

By Jakub J. Regieli, J. Wouter Jukema, Pieter A. Doevendans, Aeilko H. Zwinderman, Yolanda van der Graaf, John J. Kastelein and Diederick E. Grobbee
Topics: Original Research
Publisher: American Diabetes Association
OAI identifier: oai:pubmedcentral.nih.gov:2671091
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. Malloy MJ,KaneJP,SiestG,VisvikisS.Amultilocus genotyping assay for cardiovascular disease. Clin Chem Lab Med 1998;36: 561–566 13. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk.
    2. (2009). Peroxisome proliferator-activated receptorgamma2 P12A polymorphism and risk of coronary heart disease in US men and women. Arterioscler Thromb Vasc Biol 2005;25:1654–1658 16. RheeEJ,KwonCH,LeeWY,KimSY,Jung
    3. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.